Costs and import costs of past, present, and future TB drug regimens: a case study for Karakalpakstan, Uzbekistan.
Stefan KohlerNorman SitaliJay AcharNicolas PaulPublished in: Journal of public health (Oxford, England) (2022)
The implementation of a new and shorter DS-TB regimen may increase the costs for drug purchase and import. The implementation of new and shorter MDR-TB regimens may decrease the costs for drug purchase and/or drug import.